Studies have demonstrated cerebral insulin resistance in AD patients using ex vivo insulin stimulation and measurement of this ratio in brain tissue (Bassil et al., 2014)
Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
Building Commercial Strength and Market Access Initiatives: Companies are focused on building commercial strength by expanding globally, improving product positioning and Pricing, designing more sophisticated distribution strategies, and creating new routes to market
What Might Explain the Link
Real-World Results and Patient Experiences We measure our success by the tangible improvements our patients experience, not just on the scale, but in their overall quality of life
Distribution and characterisation of glucagon-like peptide-1 receptor expressing cells in the mouse brain